Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

NCT06535334 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.

NCT NCT06535334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06535334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Lead sponsor
Far Eastern Memorial Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2024
Completion date
May 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer